Skip to content
  • Start
  • News
  • Video
  • Podcast
  • Event
  • Premium
    • Premium Content
    • VC Database
    • Company Database
    • Soft Funding & Grants
    • Job Database
  • About BioStock
Log in Subscribe
Home / Kancera

Kancera

CEO of Novakand Pharma (formerly Kancera) leaves

Kancera seeks takeover bidder for reverse acquisition

Kancera has decided to initiate a process for...

Bioteknik
Premium

Kancera seeks interested parties for reverse acquisition

Ovarian cancer

Kancera rises on positive results from the KANDOVA study

Kancera has published positive overall results from the KANDOVA study...

Bioteknik
The news sweep

News roundup Thursday, June 5

The news sweep

News roundup Tuesday, May 27

Delay

Delayed financing lowers Kancera

On Tuesday, Kancera provided an update on the collaboration...

The news sweep

News roundup Tuesday, May 20

News roundup Monday, May 19

News roundup Wednesday April 30

Akiram Therapeutics

News roundup Monday, May 19

News roundup Thursday, April 24

BioArctic

News roundup Monday, May 19

News roundup Tuesday, April 8

Xspray Pharma

Kancera enters into a letter of intent and changes its name

Kancera has signed a letter of intent with American Recardio...

BioStock

  • Start
  • News
  • Video
  • Podcast
  • Event
  • About BioStock
  • Privacy Policy
  • Terms and Conditions

Read BioStock's newsletter

Get industry news, company information and invitations to BioStock events directly in your inbox!

Val*
This field is used for validation purposes and should be left unchanged.
© 2025 Biostock